Wet AMD drug changed by Italy government

Dr Steven Bradshaw, a drug policy expert and former ophthalmologist, is disappointed at the news of the Italian government’s decision to substitute wet age-related macular degeneration treatment drug, from Lucentis to Roche’s Avastin.

Source: Pharmacy Europe - June 16, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: Industry News avastin italy Latest News lucentis Steven Bradshaw wet age-related macular degeneration Source Type: news